Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bailey

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Lancet (London, England)|May 20, 2024
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trialShelagh B Coutts, Sandeep Ankolekar, Ramana Appireddy, et al.
Nature|February 27, 2015
Whole genomes redefine the mutational landscape of pancreatic cancerNicola Waddell, Marina Pajic, Ann-Marie Patch, et al.
Nature|February 16, 2017
Whole-genome landscape of pancreatic neuroendocrine tumoursAldo Scarpa, David K Chang, Katia Nones, et al.
Lancet (London, England)|February 15, 2025
Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trialMichael D Hill, Mayank Goyal, Andrew M Demchuk, et al.
Nature|September 28, 2017
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumoursAldo Scarpa, David K Chang, Katia Nones, et al.
Nature|February 25, 2016
Genomic analyses identify molecular subtypes of pancreatic cancerPeter Bailey, David K Chang, Katia Nones, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Lancet (London, England)|May 20, 2024
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trialShelagh B Coutts, Sandeep Ankolekar, Ramana Appireddy, et al.
Nature|February 27, 2015
Whole genomes redefine the mutational landscape of pancreatic cancerNicola Waddell, Marina Pajic, Ann-Marie Patch, et al.
Nature|February 16, 2017
Whole-genome landscape of pancreatic neuroendocrine tumoursAldo Scarpa, David K Chang, Katia Nones, et al.
Lancet (London, England)|February 15, 2025
Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trialMichael D Hill, Mayank Goyal, Andrew M Demchuk, et al.
Nature|September 28, 2017
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumoursAldo Scarpa, David K Chang, Katia Nones, et al.
Nature|February 25, 2016
Genomic analyses identify molecular subtypes of pancreatic cancerPeter Bailey, David K Chang, Katia Nones, et al.
Pageof 9